دورية أكاديمية
No evidence of disease activity in multiple sclerosis patients.
العنوان: | No evidence of disease activity in multiple sclerosis patients. |
---|---|
المؤلفون: | Matta AP; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Nascimento OJ; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Ferreira AC; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Magalhães TN; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Benevides TP; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Kirmse A; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Dib JG; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Cal H; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil., Orsini M; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil.; b Faculty of Medicine , Severino Sombra University , Vassouras , Brazil., Araujo LM; a Neurology Department , Federal Fluminense University , Rio de Janeiro , Brazil. |
المصدر: | Expert review of neurotherapeutics [Expert Rev Neurother] 2016 Nov; Vol. 16 (11), pp. 1279-1284. Date of Electronic Publication: 2016 Jul 07. |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101129944 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8360 (Electronic) Linking ISSN: 14737175 NLM ISO Abbreviation: Expert Rev Neurother Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2015- : Abingdon, Oxford : Taylor & Francis Original Publication: London : Future Drugs Ltd., 2001- |
مواضيع طبية MeSH: | Multiple Sclerosis*/diagnosis , Multiple Sclerosis*/physiopathology, Atrophy ; Disabled Persons ; Disease Progression ; Humans ; Magnetic Resonance Imaging ; Recurrence |
مستخلص: | Introduction: Multiple Sclerosis is a chronic inflammatory demyelinating disease that affects 2.5 million people in the world. NEDA (No evidence of disease Activity) -4 is a new concept related to absence of disease activity in the context of MS. It takes into account the following four parameters: relapses; disability progression; lesion load and brain atrophy. Areas covered: The purpose of this paper is to visit the new emerging concepts of NEDA. Although it is considered important and attractive, there is a lack of uniformity. Expert commentary: Although NEDA-4 embraces important markers of disease activity and degeneration, this definition is still evolving and other parameters apart from the loss of brain volume might be included, especially those related to disability, such as cognitive problems, visual function, fatigue and pain. |
فهرسة مساهمة: | Keywords: Multiple sclerosis; NEDA; demyelinating disease; drugs; neuroimmunology |
تواريخ الأحداث: | Date Created: 20160630 Date Completed: 20170703 Latest Revision: 20180518 |
رمز التحديث: | 20240628 |
DOI: | 10.1080/14737175.2016.1202763 |
PMID: | 27352830 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1744-8360 |
---|---|
DOI: | 10.1080/14737175.2016.1202763 |